News
Media
Conferences
Publication
Job Board
CME/CE
Partners
Editorial
Resources
Subscribe

Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Arsalan Nisar, MS

Articles by Arsalan Nisar, MS

Ktsdesign/AdobeStock

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review

ByParas Gupta, MBE,Sarah Hakam, BS,Arsalan Nisar, MS,Inna D'Empaire, MD,Gina Jamal, MD,Reza Safavi, MD

February 3rd 2025

What patients are at risk when taking SSRIs?

Latest Updated Articles

The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review
February 3rd 2025

Trending on Psychiatric Times

PET Imaging Confirms Lower Muscarinic M1 Receptor Availability in Schizophrenia

Making Sense of the New Alzheimer Treatment Landscape, With Aaron Ritter, MD

What's New in Psychiatric Treatment? Highlights From the 2026 Southern California Psychiatry Conference

Real-World and Long-Term Trial Data Show Xanomeline/Trospium Cuts Hospitalizations, Antipsychotic Burden in Schizophrenia

The Weight of Performance: Athletic Identity and Eating Disorders in Male Athletes